VOYA Investment Management
CAPR icon

VOYA Investment Management’s Capricor Therapeutics CAPR Stock Holding History

VOYA Investment Management’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$251K Buy
10,432
+3,012
+41% +$91.3K ﹤0.01% 2132
2026
Q1 		$226K Buy
+7,420
New +$198K ﹤0.01% 2072
2025
Q3 		– Sell
-10,644
Closed -$106K – 2473
2025
Q2 		$106K Buy
10,644
+367
+4% +$3.88K ﹤0.01% 2482
2025
Q1 		$97.5K Sell
10,277
-573
-5% -$7.95K ﹤0.01% 2440
2024
Q4 		$150K Buy
+10,850
New +$190K ﹤0.01% 2478

Other funds holding CAPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

VOYA Investment Management's CAPR Position: Q2 2026 in Review

VOYA Investment Management increased its Capricor Therapeutics (CAPR) stake by 41% in Q2 2026, buying an estimated $91.3K and bringing the position to 10,432 shares worth $251K. The position accounts for ﹤0.01% of the portfolio, ranked #2132.

VOYA Investment Management first reported a position in CAPR in Q4 2024 and has held it in 5 quarters since. 169 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

  • VOYA Investment Management held 10,432 shares of Capricor Therapeutics worth $251K as of Q2 2026.
  • VOYA Investment Management bought 3,012 Capricor Therapeutics shares in Q2 2026, an estimated $91.3K.
  • Capricor Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #2132 holding.
  • VOYA Investment Management first reported a position in Capricor Therapeutics in Q4 2024 and has held it in 5 quarters since.
  • 169 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.